Home / Private raises / Galvanize Therapeutics, Inc.
Galvanize Therapeutics, Inc.
Biotechnology · Redwood City, California · $136M sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-11-18 | D (new) | $136M | $136M | 26 | 506(b) | Equity | Nov 6 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Issuer
| Industry | Biotechnology |
| Located | Redwood City, California |
| Entity | Corporation |
| Incorporated | Delaware |
| SEC CIK | 1659073 |
People named in the latest filing
| Name | Role |
|---|---|
| Doug Godshall | Executive Officer, Director |
| Seth Harrison | Director |
| Antoine Papiernik | Director |
| Zack Scott | Director |
| David Lewis | Director |
| Steve Anheier | Executive Officer |
| Isaac Zacharias | Director |
| Laura Francis | Director |
| Garheng Kong | Director |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
